C030.DE
Amundi DJ Switzerland Titans 30 UCITS ETF Dist
Europe
EQUITY
Passive
MANAGEMENT STYLE
€ 188.7 M
ASSETS UNDER MGMT
25 bp
EXPENSES
Fund Basics
| Inception date | Dec 07, 2023 |
| Regulation | UCITs |
| ISIN | LU2611732632 |
| Distributions | Annually |
| Currency | EUR |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
| NOVARTIS AG | 10.8 % |
| ROCHE HOLDING AG-BR | 10.7 % |
| UBS GROUP AG | 9.5 % |
| NESTLE SA-REG | 9.1 % |
| ABB LTD. | 7.9 % |
| CIE FINANCIERE RICHEMON-BR A | 6.9 % |
| ZURICH FINANCIAL SERVICES AG | 6.7 % |
| HOLCIM LTD-REG | 3.4 % |
| LONZA GROUP AG-REG | 3.3 % |
| SWISS RE AG | 3.1 % |
Constituent Breakdown
| Number of holdings | 33 |
| Herfindahl-Hirschman Index | 637 |
| Wgt avg mkt cap (mns) | $109,804 |
| Large cap (>$10bn) | 96.3% |
| Mid cap ($2-10bn) | 0.6% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 96.9% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
SWITZERLAND | 98.2 % |
Historical Performance
Standardized Performance (as of 02/28/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 6.5% | 11.4% | 14.2% | -- | -- | -- | -- | 15.3% |
| Dividend Yield | 0.0% | 1.5% | 1.6% | -- | -- | -- | -- | 1.5% |
| Total Returns | 6.5% | 12.9% | 15.8% | -- | -- | -- | -- | 16.8% | Ann. Volatility | 10.1% | 15.3% | 13.3% | -- | -- | -- | -- | 13.1% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.08 | 1% |
| MSCI EAFE | 0.29 | 10% |
| MSCI Emg Mkts | 0.18 | 5% |
Liquidity Measures
| Avg. volume (000) | 1 |
| ADV traded (mns) | $0 |
| Turnover | 0.1% |
| Avg. Bid/Ask (% of price) | 0.00% |
Technical Indicators
| 30d moving avg. (EMA) | $190.22 |
| Relative strength (RSI) | 69 |
| MACD/Signal | 2.56/2.24 |
| Bollinger Bands (Upper/Lower) | $197.08/$185.77 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. C030.DE |
Expenses vs. C030.DE |
ALTAR Score™ vs. C030.DE |
|---|---|---|---|---|
| XSLI.DE | Xtrackers SLI UCITS ETF 1D | 69.5% | 0 bp | +0.5% |
| XSMC.SW | Xtrackers Switzerland UCITS ETF 1C | 63.4% | +5 bp | +0.6% |
| XSMI.DE | Xtrackers Switzerland UCITS ETF 1D | 62.9% | +5 bp | +0.7% |
| ESIH.L | iShares MSCI Europe Health Care Sector UCITS ETF | 29.4% | -7 bp | +1.1% |
| EXV4.DE | iShares STOXX Europe 600 Health Care UCITS ETF (DE) | 29.2% | +21 bp | +0.8% |
| IEFQ.L | iShares Edge MSCI Europe Quality Factor UCITS ETF | 22.4% | 0 bp | +0.6% |
| IEQD.L | iShares Edge MSCI Europe Quality Factor UCITS ETF | 22.4% | 0 bp | +0.6% |
| ESDU.L | Amundi MSCI Europe SRI Climate Paris Aligned UCITS ETF DR (D | 19.0% | -7 bp | -5.8% |
| ESRG.L | Amundi MSCI Europe SRI Climate Paris Aligned UCITS ETF DR (C | 19.0% | -7 bp | +0.1% |
| XSDR.DE | Xtrackers MSCI Europe Health Care Screened UCITS ETF 1C | 18.8% | -8 bp | +1.0% |
Risk and Returns: C030.DE vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (EUR)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 4/5/2026
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
5.8%
ALTAR SCORE™
14th
PERCENTILE
AVOID
ETFRC RATING
There are 239 funds in the Europe Equity category with an average
ALTAR Score™ of 7.2% and a standard deviation
of 1.3%. C030.DE's ALTAR Score™ is approximately -1.1 standard
deviations above the category average. This places C030.DE in the 14th percentile
among funds in the category.
Sell-Side Consensus
€208.16
PRICE TARGET
+14.7%
UPSIDE